Anti-infective VNAs

Saul Tzipori Charles Shoemaker The Department of Infectious Disease and Global Health is developing a novel anti-infection platform employing VHH-based neutralizing agents (VNAs) engineered for the prevention and treatment of infectious diseases, primarily for applications as enteric disease therapies. The department’s anti-infective strategy is to engineer VNAs that interfere in the motility of pathogens or their ability to […]